These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36694460)

  • 21. Patient perspectives on emergency department initiation of medication for alcohol use disorder.
    Forsgren E; Steiger A; Perez Y; Salazar D; McCollough M; Taira BR
    Acad Emerg Med; 2024 May; 31(5):471-480. PubMed ID: 37326129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APRN prescribing in Georgia: An evolving environment.
    Shilling DL; Hodnicki D
    J Am Assoc Nurse Pract; 2015 Jun; 27(6):300-7. PubMed ID: 25546247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practice Analysis: Adult-Gerontology Acute Care Nurse Practitioner and Clinical Nurse Specialist.
    Becker D; Dechant LM; McNamara LJ; Konick-McMahon J; Noe CA; Thomas K; Fabrey LJ
    Am J Crit Care; 2020 Mar; 29(2):e19-e30. PubMed ID: 32114613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of publicly funded naltrexone use among patients diagnosed with alcohol use disorder in Ontario.
    Tourchian N; McCormack D; Leece P; Tadrous M; Gomes T
    Alcohol Alcohol; 2024 Jan; 59(2):. PubMed ID: 38300604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence with naltrexone prescription advice in hospital outpatient alcohol rehabilitation programme.
    Feeney GF; Connor JP; Young RM; Tucker J; Czajkowski F
    J Clin Pharm Ther; 2001 Feb; 26(1):73-9. PubMed ID: 11286610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.
    Greenfield SF; Pettinati HM; O'Malley S; Randall PK; Randall CL
    Alcohol Clin Exp Res; 2010 Oct; 34(10):1803-12. PubMed ID: 20645934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Provider perspectives on emergency department initiation of medication assisted treatment for alcohol use disorder.
    Philippine T; Forsgren E; DeWitt C; Carter I; McCollough M; Taira BR
    BMC Health Serv Res; 2022 Apr; 22(1):456. PubMed ID: 35392901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding US addiction physicians' low rate of naltrexone prescription.
    Mark TL; Kranzler HR; Song X
    Drug Alcohol Depend; 2003 Sep; 71(3):219-28. PubMed ID: 12957340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007-2017.
    McBain RK; Dick A; Sorbero M; Stein BD
    Ann Intern Med; 2020 Apr; 172(7):504-506. PubMed ID: 31905379
    [No Abstract]   [Full Text] [Related]  

  • 30. Medication treatment for alcohol use disorder in special populations.
    Malhotra A; Drexler K; Hsu M; Tang YL
    Am J Addict; 2023 Sep; 32(5):433-441. PubMed ID: 37551638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacotherapy for alcohol use disorder among adults with medical disorders in Sweden.
    Månsson A; Danielsson AK; Sjöqvist H; Glatz T; Lundin A; Wallhed Finn S
    Addict Sci Clin Pract; 2024 May; 19(1):41. PubMed ID: 38764075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buprenorphine prescribing by APRNs.
    Rundio A
    J Addict Nurs; 2012 Feb; 23(1):80-1. PubMed ID: 22468666
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of COVID-19 pandemic on APRN practice: Results from a national survey.
    Kleinpell R; Myers CR; Schorn MN; Likes W
    Nurs Outlook; 2021; 69(5):783-792. PubMed ID: 34176669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A survey of nurse practitioner controlled drugs and substances prescribing in three Canadian provinces.
    O'Rourke T; Kirk J; Duff E; Golonka R
    J Clin Nurs; 2019 Dec; 28(23-24):4342-4356. PubMed ID: 31318988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementation of Oral and Extended-Release Naltrexone for the Treatment of Emergency Department Patients With Moderate to Severe Alcohol Use Disorder: Feasibility and Initial Outcomes.
    Anderson ES; Chamberlin M; Zuluaga M; Ullal M; Hawk K; McCormack R; D'Onofrio G; Herring AA
    Ann Emerg Med; 2021 Dec; 78(6):752-758. PubMed ID: 34353648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perspectives on APRN prescribing of medications for opioid use disorder: Key barriers remain.
    Chapman SA; Fraimow-Wong L; Phoenix BJ; Tierney M; Spetz J
    J Subst Use Addict Treat; 2024 Feb; 157():209215. PubMed ID: 37979946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication prescribing for alcohol use disorders during alcohol-related encounters in a Colorado regional healthcare system.
    Chockalingam L; Burnham EL; Jolley SE
    Alcohol Clin Exp Res; 2022 Jun; 46(6):1094-1102. PubMed ID: 35723682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prescribing of buprenorphine by advanced practice addictions nurses.
    Strobbe S; Hobbins D
    J Addict Nurs; 2012 Feb; 23(1):82-3. PubMed ID: 22468667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-medical prescribing: a reflective case study on prescribing anticoagulation for deep vein thrombosis.
    Gonet S
    Emerg Nurse; 2019 Jul; 27(4):30-32. PubMed ID: 31468849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychiatric Nursing Workforce Survey: Results and Implications.
    Gerolamo AM; Delaney KR; Phoenix B; Black P; Rushton A; Stallings J
    J Am Psychiatr Nurses Assoc; 2024; 30(3):690-696. PubMed ID: 36582042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.